OrbusNeich Medical Group Holdings Limited

HKSE 6929.HK

OrbusNeich Medical Group Holdings Limited Total Assets for the year ending December 31, 2023: USD 410.14 M

OrbusNeich Medical Group Holdings Limited Total Assets is USD 410.14 M for the year ending December 31, 2023, a 16.83% change year over year. Total assets are the total value of all assets owned by a company, representing its resources.
  • OrbusNeich Medical Group Holdings Limited Total Assets for the year ending December 31, 2022 was USD 351.06 M, a 30.74% change year over year.
  • OrbusNeich Medical Group Holdings Limited Total Assets for the year ending December 31, 2021 was USD 268.53 M, a 159.08% change year over year.
  • OrbusNeich Medical Group Holdings Limited Total Assets for the year ending December 31, 2020 was USD 103.65 M, a 8.31% change year over year.
  • OrbusNeich Medical Group Holdings Limited Total Assets for the year ending December 31, 2019 was USD 95.69 M.
Key data
Date Total Assets Current Liabilities Total Non-Current Liabilities Shareholders' Equity
Market news
Loading...
SV Wall Street
HKSE: 6929.HK

OrbusNeich Medical Group Holdings Limited

Description

OrbusNeich Medical Group Holdings Limited, an investment holding company, manufactures, trades in, sells, and markets medical devices/instruments used for the treatment of coronary and peripheral vascular diseases in Japan, Europe, the Middle East, Africa, the Asia Pacific, the People's Republic of China, and the United States. The company offers semi-compliant balloons and scoring balloons for pre-dilatation and lesion preparation, coronary stents for implantation, non-compliant balloons for post-dilatation, and specialty catheters. Its product portfolio covers various treatment processes in percutaneous coronary intervention (PCI) and percutaneous transluminal angioplasty (PTA) procedures. The company was founded in 2001 and is headquartered in Shatin, Hong Kong. OrbusNeich Medical Group Holdings Limited is a subsidiary of Harmony Tree Limited.

StockViz Staff

February 3, 2025

Any question? Send us an email